Functional and structural biomarkers linked to diabetic retinal neurodegeneration in pre-clinical and early diabetic retinopathy

与临床前和早期糖尿病视网膜病变中糖尿病视网膜神经退行性变相关的功能和结构生物标志物

阅读:1

Abstract

BACKGROUND: Diabetic retinal neurodegeneration (DRN) is increasingly recognised as an early and progressive neuronal dysfunction. Despite emerging therapeutic approaches, there are no standardised biomarkers. We aim to investigate functional and structural biomarkers of DRN in people with diabetes (PWD) with no or early diabetic retinopathy (DR). METHODS: Functional measures included handheld radial shape discrimination (hRSD), near and distant visual acuity (VA). Structural changes were evaluated using optical coherence tomography (OCT)-derived retinal thicknesses (Early Treatment Diabetic Retinopathy Study (ETDRS) subfields). Mean thicknesses of the inner and outer ETDRS subfields were averaged to derive inner and outer ring estimates. Pearson’s correlation assessed associations between normally distributed variables. Group differences were analysed using Student’s t-test for continuous data, Chi-squared or Fisher’s exact tests for categorical variables, and one-way ANOVA with Bonferroni-adjusted post hoc tests for multiple groups. RESULTS: The study included a single eye from 50 healthy participants (HP; Group 1, 55 ± 14y), 26 PWD with no DR (Group 2, 55 ± 14y), and 46 with early DR (Group 3, 57 ± 17y). hRSD and VA were worse in Groups 1 to 3 (all p < 0.001). Worse function (measured via hRSD) was associated with inner retinal thinning (p < 0.05). Compared to HP, PWD (Groups 2 and 3) showed thinning of the total retina (most subfields), retinal nerve fibre layer (RNFL; outer ETDRS ring), ganglion cell layer (GCL) and inner plexiform layer (IPL) in the inner ring, and outer nuclear layer (ONL) in the central subfield (CSF) (p < 0.05). Group 3 also showed GCL and IPL thinning (outer ring) (p < 0.05). In 23 PWD followed over 205 ± 109 days, GCL, IPL, and inner nuclear layer (INL) thicknesses decreased (p < 0.05). CONCLUSIONS: Functional and structural changes occur early in DR. hRSD and retinal thicknesses are promising biomarkers for DRN. Longitudinal data suggest DRN to be progressive. CLINICAL TRIAL NUMBER: Not applicable.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。